Simultaneous silencing of TGF-β1 and COX-2 reduces human skin hypertrophic scar through activation of fibroblast apoptosis-Reference-Cited by-同舟云学术

Simultaneous silencing of TGF-β1 and COX-2 reduces human skin hypertrophic scar through activation of fibroblast apoptosis

Published:2017-09-14 Issue:46 Volume:8 Page:80651-80665
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Zhou Jia¹,Zhao Yixuan¹,Simonenko Vera²,Xu John J.³,Liu Kai¹,Wang Deling³,Shi Jingli³,Zhong Tianyi³,Zhang Lixia³,Zeng Lun⁴,Huang Bin⁴,Tang Shenggao⁵,Lu Alan Y.⁵,Mixson A. James⁶,Sun Yangbai¹,Lu Patrick Y.²,Li Qingfeng¹

Affiliation:

1. Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

2. Sirnaomics, Inc., Gaithersburg, MD, USA

3. Suzhou Sirnaomics Pharmaceuticals, Ltd., Biobay, Suzhou, China

4. Guangzhou Xiangxue Pharmaceuticals, Co. Ltd., Guangzhou, China

5. Guangzhou Nanotides Pharmaceuticals, Co. Ltd., Guangzhou, China

6. Department of Pathology, School of Medicine, University of Maryland, Baltimore, MD, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Silver and gold nanoparticles as a novel approach to fight Sarcoptic mange in rabbits;Scientific Reports;2024-05-09

2. Recent Progress of Small Interfering RNA Delivery on the Market and Clinical Stage;Molecular Pharmaceutics;2024-04-17

3. Nucleic acid-based drugs for patients with solid tumours;Nature Reviews Clinical Oncology;2024-04-08

4. Nucleic Acid Therapeutics: Successes, Milestones, and Upcoming Innovation;Nucleic Acid Therapeutics;2024-04-01

5. Codelivery of TGFβ and Cox2 siRNA inhibits HCC by promoting T-cell penetration into the tumor and improves response to Immune Checkpoint Inhibitors;NAR Cancer;2024-01-09